Trump Administration's Rx Drug Price Disclosure Reg Seen As Unworkable
Executive Summary
Lawyers say CMS proposed rule requiring TV ads to disclose drug's list price wouldn't survive First Amendment suit and competitors have no reason to try to enforce it.
You may also be interested in...
After DTC Rule Tossed Out In Court, Attention Turns (Again) To Congress
HHS lacks authority to require drug price disclosures in TV ads, judge rules. Even if legislation were to explicitly give the Trump Administration such authority, First Amendment issues would still linger.
DTC Ad Final Rule Means Reliance On PhRMA Program Risks Enforcement Action – Azar
Nevertheless, the Pharmaceutical Research and Manufacturers of America announces enhancement of its voluntary drug pricing disclosures program, a Medicines Assistance Tool website that links to individual company sites, in response to the US rule.
DTC Ad Final Rule Means Reliance On PhRMA Program Risks Enforcement Action – Azar
Nevertheless, the Pharmaceutical Research and Manufacturers of America announces enhancement of its drug pricing disclosures voluntary program, a Medicines Assistance Tool website that links to individual company sites, in response to the US rule.